Skip to content

塞尔库伊蒂

US · CELC #2398 按市值排名 上市于 2017
56.58 -3.72 -6.17%
实时 - 追踪5344个代码 - 心跳于526秒前 · 2026-10-16 20:02

最新新闻

  • H.C. Wainwright Maintains Celcuity(CELC.US) With Buy Rating, Maintains Target Price $155
    \u5e02\u573a\u8d44\u8baf · 2026/10/1
  • 评级变动
    A Quick Look at Today's Ratings for Celcuity(CELC.US), With a Forecast Between $155 to $178
    \u5e02\u573a\u8d44\u8baf · 2026/7/16
  • 评级变动
    Stifel Maintains Celcuity(CELC.US) With Buy Rating, Cuts Target Price to $150
    \u5e02\u573a\u8d44\u8baf · 2026/8/14
  • 评级变动
    A Quick Look at Today's Ratings for Celcuity(CELC.US), With a Forecast Between $155 to $177
    \u5e02\u573a\u8d44\u8baf · 2026/7/15
  • 评级变动
    A Quick Look at Today's Ratings for Celcuity(CELC.US), With a Forecast Between $145 to $166
    \u5e02\u573a\u8d44\u8baf · 2026/6/3
  • 评级变动
    LifeSci Capital Maintains Celcuity(CELC.US) With Buy Rating, Maintains Target Price $165
    \u5e02\u573a\u8d44\u8baf · 2026/5/16
  • 评级变动
    A Quick Look at Today's Ratings for Celcuity(CELC.US), With a Forecast Between $140 to $166
    \u5e02\u573a\u8d44\u8baf · 2026/8/15
  • 评级变动
    Wells Fargo Maintains Celcuity(CELC.US) With Buy Rating, Maintains Target Price $166
    \u5e02\u573a\u8d44\u8baf · 2026/8/14
  • 评级变动
    Analysts Offer Insights on Healthcare Companies: Neumora Therapeutics, Inc. (NMRA), Celcuity (CELC) and Parabilis Medicines, Inc. (PBLS)
    TipRanks · 2026/8/15
  • 评级变动
    A Quick Look at Today's Ratings for Celcuity(CELC.US), With a Forecast Between $145 to $171
    \u5e02\u573a\u8d44\u8baf · 2026/6/4
  • 评级变动
    H.C. Wainwright Maintains Celcuity(CELC.US) With Buy Rating, Raises Target Price to $185
    \u5e02\u573a\u8d44\u8baf · 2026/5/18
  • J.P. Morgan Initiates Celcuity(CELC.US) With Buy Rating, Announces Target Price $157
    \u5e02\u573a\u8d44\u8baf · 2026/9/18
  • Celcuity (CELC) Gets a Buy From H.C. Wainwright
    TipRanks · 2026/10/1
  • Needham Maintains Celcuity(CELC.US) With Buy Rating, Cuts Target Price to $134
    \u5e02\u573a\u8d44\u8baf · 2026/10/1
  • Guggenheim Maintains Celcuity(CELC.US) With Buy Rating, Raises Target Price to $175
    \u5e02\u573a\u8d44\u8baf · 2026/8/17
  • 公司公告
    Celcuity: Celcuity Inc. - Flex Position Consolidation Option Symbol: 1CELC
    OCC · 2026/4/24
  • 评级变动
    Needham Maintains Celcuity(CELC.US) With Buy Rating, Cuts Target Price to $140
    \u5e02\u573a\u8d44\u8baf · 2026/8/14
  • 评级变动
    Craig-Hallum Maintains Celcuity(CELC.US) With Buy Rating, Cuts Target Price to $173
    \u5e02\u573a\u8d44\u8baf · 2026/8/18
  • 评级变动
    A Quick Look at Today's Ratings for Celcuity(CELC.US), With a Forecast Between $157 to $183
    \u5e02\u573a\u8d44\u8baf · 2026/5/15
  • 评级变动
    Stifel Maintains Celcuity(CELC.US) With Buy Rating, Raises Target Price to $175
    \u5e02\u573a\u8d44\u8baf · 2026/5/15

新闻标题为自动聚合内容,未经我们团队独立核实或编辑。

报价时间 2026-10-16 20:02:25 · 仅供参考,不构成投资建议,也未考虑您的具体情况。

塞尔库伊蒂 讨论区 0 条评论

发表评论